THE RELEVANT PUBLIC FOR PHARMACEUTICAL TRADEMARKS : PROFESSIONAL OR MEDICINE CHEST?
The European Court of First Instance ruled on September 22, 2005, in TRIVASTAN vs./ TRAVATAN, that both professionals and end-consumers were the relevant public of pharmaceutical trademarks since medicine is delivered by professionals and then, a choice is made by the end-user in front of the medicine chest.